| scholarly article | Q13442814 |
| editorial | Q871232 |
| P2093 | author name string | G R Hughes | |
| P433 | issue | 4 | |
| P304 | page(s) | 285-286 | |
| P577 | publication date | 1985-10-01 | |
| P1433 | published in | Clinical and Experimental Rheumatology | Q15759225 |
| P1476 | title | The anticardiolipin syndrome | |
| P478 | volume | 3 |
| Q35250419 | "New" antigenic targets and methodological approaches for refining laboratory diagnosis of antiphospholipid syndrome |
| Q64934761 | A Monocentric Cohort of Obstetric Seronegative Anti-Phospholipid Syndrome. |
| Q26780481 | Altered Traffic of Cardiolipin during Apoptosis: Exposure on the Cell Surface as a Trigger for "Antiphospholipid Antibodies" |
| Q81512797 | Anti-lysobisphosphatidic acid antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus |
| Q39273389 | Antibody to phosphatidylethanolamine in a patient with lupus anticoagulant and thrombosis |
| Q36707524 | Anticardiolipin antibodies--clinical associations |
| Q35719544 | Anticardiolipin antibody |
| Q90312441 | Antiphospholipid Antibodies: Their Origin and Development |
| Q35647424 | Antiphospholipid antibodies and stroke |
| Q35630097 | Antiphospholipid reactivity against cardiolipin metabolites occurring during endothelial cell apoptosis |
| Q37045158 | Antiphospholipid syndrome and vascular ischemic (occlusive) diseases: an overview |
| Q34271982 | Antiphospholipid syndrome, antiphospholipid antibodies, and atherosclerosis |
| Q33561642 | Antiphospholipid syndrome: linking many specialties |
| Q71992268 | Antiphospholipids--a "guilty ghost" syndrome |
| Q44461543 | Beta-2-glycoprotein I expression on monocytes is increased in anti-phospholipid antibody syndrome and correlates with tissue factor expression |
| Q33932513 | Biological false positive serological tests for syphilis in the Jamaican population |
| Q33398955 | Clinical implications of elevated antiphospholipid antibodies in adult patients with primary immune thrombocytopenia |
| Q84345748 | Detection of anticardiolipin antibody IgG by time-resolved fluoroimmunoassay |
| Q47998109 | Diagnosing antiphospholipid syndrome: 'extra-criteria' manifestations and technical advances |
| Q37351603 | Independent association of anti-beta(2)-glycoprotein I antibodies with macrovascular disease and mortality in scleroderma patients |
| Q37352874 | Infections and the antiphospholipid syndrome |
| Q33999868 | Intracardiac thrombosis, phospholipid antibodies, and two-chambered right ventricle |
| Q45862435 | Lack of correlation between anticardiolipin antibodies and peripheral autonomic nerve involvement in systemic lupus erythematosus |
| Q39608521 | Long-term use of hydroxychloroquine reduces antiphospholipid antibodies levels in patients with primary antiphospholipid syndrome |
| Q34499518 | Lupus vasculitis: differential diagnosis with antiphospholipid syndrome |
| Q34534532 | Multiple steno-obstructive vascular lesions and femoral superficial artery dissection in a young Caucasian male with antiphospholipid syndrome |
| Q33433089 | Primary antiphospholipid syndrome: features of patients with raised anticardiolipin antibodies and no other disorder |
| Q33557479 | Prostacyclin in systemic lupus and anticardiolipin syndrome |
| Q33557638 | Recurrent stroke and multi-infarct dementia in systemic lupus erythematosus: association with antiphospholipid antibodies |
| Q35549777 | Right ventricular diastolic dysfunction in patients with anticardiolipin antibodies and antiphospholipid syndrome |
| Q73738644 | Specificity of anti-phospholipid antibodies in infectious mononucleosis: a role for anti-cofactor protein antibodies |
| Q33766710 | Testing for and clinical significance of anticardiolipin antibodies |
| Q37704857 | The mosaic of "seronegative" antiphospholipid syndrome |
| Q34108969 | The pathogenic role of annexin-V in the antiphospholipid syndrome |
| Q87114991 | The spectrum between antiphospholipid syndrome and systemic lupus erythematosus |
| Q90484321 | Tissue factor over-expression in platelets of patients with anti-phospholipid syndrome: induction role of anti-β2-GPI antibodies |
Search more.